Medical - Care Facilities
Compare Stocks
4 / 10Stock Comparison
HCSG vs WELL vs SBRA vs NHI
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Healthcare Facilities
REIT - Healthcare Facilities
HCSG vs WELL vs SBRA vs NHI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Care Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $1.60B | $149.25B | $5.19B | $3.64B |
| Revenue (TTM) | $1.84B | $11.63B | $813M | $403M |
| Net Income (TTM) | $59M | $1.43B | $156M | $148M |
| Gross Margin | 13.3% | 39.1% | 63.5% | 61.3% |
| Operating Margin | 3.0% | 4.4% | 29.0% | 48.5% |
| Forward P/E | 20.8x | 78.4x | 29.8x | 22.2x |
| Total Debt | $25M | $21.38B | $2.55B | $1.16B |
| Cash & Equiv. | $161M | $5.03B | $72M | $20M |
HCSG vs WELL vs SBRA vs NHI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Healthcare Services… (HCSG) | 100 | 93.3 | -6.7% |
| Welltower Inc. (WELL) | 100 | 420.4 | +320.4% |
| Sabra Health Care R… (SBRA) | 100 | 152.9 | +52.9% |
| National Health Inv… (NHI) | 100 | 135.3 | +35.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HCSG vs WELL vs SBRA vs NHI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HCSG carries the broadest edge in this set and is the clearest fit for value and momentum.
- Lower P/E (20.8x vs 22.2x)
- +55.8% vs NHI's +2.8%
- 7.3% ROA vs WELL's 2.3%, ROIC 9.0% vs 0.5%
WELL is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 2 yrs, beta 0.13, yield 1.3%
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 223.1% 10Y total return vs NHI's 58.9%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
SBRA lags the leaders in this set but could rank higher in a more targeted comparison.
NHI is the clearest fit if your priority is quality.
- 36.8% margin vs HCSG's 3.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs HCSG's 7.1% | |
| Value | Lower P/E (20.8x vs 22.2x) | |
| Quality / Margins | 36.8% margin vs HCSG's 3.2% | |
| Stability / Safety | Beta 0.13 vs HCSG's 1.12 | |
| Dividends | 1.3% yield, 2-year raise streak, vs SBRA's 5.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +55.8% vs NHI's +2.8% | |
| Efficiency (ROA) | 7.3% ROA vs WELL's 2.3%, ROIC 9.0% vs 0.5% |
HCSG vs WELL vs SBRA vs NHI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HCSG vs WELL vs SBRA vs NHI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HCSG leads in 2 of 6 categories
NHI leads 1 • WELL leads 1 • SBRA leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NHI leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 28.9x NHI's $403M. NHI is the more profitable business, keeping 36.8% of every revenue dollar as net income compared to HCSG's 3.2%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1.8B | $11.6B | $813M | $403M |
| EBITDAEarnings before interest/tax | $72M | $2.8B | $432M | $282M |
| Net IncomeAfter-tax profit | $59M | $1.4B | $156M | $148M |
| Free Cash FlowCash after capex | $139M | $2.5B | $367M | $226M |
| Gross MarginGross profit ÷ Revenue | +13.3% | +39.1% | +63.5% | +61.3% |
| Operating MarginEBIT ÷ Revenue | +3.0% | +4.4% | +29.0% | +48.5% |
| Net MarginNet income ÷ Revenue | +3.2% | +12.3% | +19.2% | +36.8% |
| FCF MarginFCF ÷ Revenue | +7.6% | +21.9% | +45.1% | +56.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.6% | +40.3% | +20.8% | +29.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +175.0% | +22.5% | -5.9% | +10.8% |
Valuation Metrics
HCSG leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 24.9x trailing earnings, NHI trades at a 84% valuation discount to WELL's 153.3x P/E. On an enterprise value basis, SBRA's 17.0x EV/EBITDA is more attractive than WELL's 66.4x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.6B | $149.2B | $5.2B | $3.6B |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $165.6B | $7.7B | $4.8B |
| Trailing P/EPrice ÷ TTM EPS | 27.54x | 153.25x | 32.16x | 24.85x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.83x | 78.42x | 29.83x | 22.17x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 22.38x | 66.40x | 17.01x | 17.16x |
| Price / SalesMarket cap ÷ Revenue | 0.87x | 13.99x | 6.70x | 9.61x |
| Price / BookPrice ÷ Book value/share | 3.19x | 3.35x | 1.78x | 2.29x |
| Price / FCFMarket cap ÷ FCF | 11.49x | 52.41x | 14.89x | 16.52x |
Profitability & Efficiency
HCSG leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
HCSG delivers a 11.8% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $3 for WELL. HCSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to SBRA's 0.90x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs SBRA's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +11.8% | +3.5% | +5.6% | +9.8% |
| ROA (TTM)Return on assets | +7.3% | +2.3% | +2.8% | +5.4% |
| ROICReturn on invested capital | +9.0% | +0.5% | +3.8% | +5.6% |
| ROCEReturn on capital employed | +7.7% | +0.6% | +5.2% | +8.0% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.05x | 0.49x | 0.90x | 0.76x |
| Net DebtTotal debt minus cash | -$136M | $16.3B | $2.5B | $1.1B |
| Cash & Equiv.Liquid assets | $161M | $5.0B | $72M | $20M |
| Total DebtShort + long-term debt | $25M | $21.4B | $2.6B | $1.2B |
| Interest CoverageEBIT ÷ Interest expense | 33.02x | 0.26x | 2.40x | 3.45x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $7,888 for HCSG. Over the past 12 months, HCSG leads with a +55.8% total return vs NHI's +2.8%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs HCSG's 14.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +28.6% | +14.3% | +9.0% | -1.1% |
| 1-Year ReturnPast 12 months | +55.8% | +42.7% | +20.5% | +2.8% |
| 3-Year ReturnCumulative with dividends | +48.6% | +189.5% | +113.0% | +73.5% |
| 5-Year ReturnCumulative with dividends | -21.1% | +202.3% | +49.9% | +31.0% |
| 10-Year ReturnCumulative with dividends | -26.8% | +223.1% | +50.9% | +58.9% |
| CAGR (3Y)Annualised 3-year return | +14.1% | +42.5% | +28.7% | +20.2% |
Risk & Volatility
Evenly matched — SBRA and NHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
NHI is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than HCSG's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SBRA currently trades 97.7% from its 52-week high vs NHI's 82.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 0.13x | -0.06x | -0.08x |
| 52-Week HighHighest price in past year | $24.39 | $219.59 | $21.07 | $90.94 |
| 52-Week LowLowest price in past year | $12.66 | $142.65 | $17.08 | $68.80 |
| % of 52W HighCurrent price vs 52-week peak | +91.5% | +97.0% | +97.7% | +82.5% |
| RSI (14)Momentum oscillator 0–100 | 61.8 | 60.2 | 54.5 | 28.0 |
| Avg Volume (50D)Average daily shares traded | 676K | 2.6M | 2.1M | 332K |
Analyst Outlook
Evenly matched — HCSG and SBRA each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HCSG as "Hold", WELL as "Buy", SBRA as "Hold", NHI as "Hold". Consensus price targets imply 13.8% upside for NHI (target: $85) vs 3.0% for SBRA (target: $21). For income investors, SBRA offers the higher dividend yield at 5.75% vs WELL's 1.30%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $24.50 | $226.50 | $21.20 | $85.40 |
| # AnalystsCovering analysts | 15 | 34 | 29 | 18 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% | +5.8% | +4.8% |
| Dividend StreakConsecutive years of raises | 20 | 2 | 0 | 1 |
| Dividend / ShareAnnual DPS | — | $2.76 | $1.18 | $3.61 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.9% | 0.0% | 0.0% | 0.0% |
HCSG leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). NHI leads in 1 (Income & Cash Flow). 2 tied.
HCSG vs WELL vs SBRA vs NHI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HCSG or WELL or SBRA or NHI a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 7. 1% for Healthcare Services Group, Inc. (HCSG). National Health Investors, Inc. (NHI) offers the better valuation at 24. 9x trailing P/E (22. 2x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HCSG or WELL or SBRA or NHI?
On trailing P/E, National Health Investors, Inc.
(NHI) is the cheapest at 24. 9x versus Welltower Inc. at 153. 3x. On forward P/E, Healthcare Services Group, Inc. is actually cheaper at 20. 8x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — HCSG or WELL or SBRA or NHI?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -21. 1% for Healthcare Services Group, Inc. (HCSG). Over 10 years, the gap is even starker: WELL returned +223. 1% versus HCSG's -26. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HCSG or WELL or SBRA or NHI?
By beta (market sensitivity over 5 years), National Health Investors, Inc.
(NHI) is the lower-risk stock at -0. 08β versus Healthcare Services Group, Inc. 's 1. 12β — meaning HCSG is approximately -1438% more volatile than NHI relative to the S&P 500. On balance sheet safety, Healthcare Services Group, Inc. (HCSG) carries a lower debt/equity ratio of 5% versus 90% for Sabra Health Care REIT, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HCSG or WELL or SBRA or NHI?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 7. 1% for Healthcare Services Group, Inc. (HCSG). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HCSG or WELL or SBRA or NHI?
National Health Investors, Inc.
(NHI) is the more profitable company, earning 37. 6% net margin versus 3. 2% for Healthcare Services Group, Inc. — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus 2. 6% for HCSG. At the gross margin level — before operating expenses — SBRA leads at 65. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HCSG or WELL or SBRA or NHI more undervalued right now?
On forward earnings alone, Healthcare Services Group, Inc.
(HCSG) trades at 20. 8x forward P/E versus 78. 4x for Welltower Inc. — 57. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NHI: 13. 8% to $85. 40.
08Which pays a better dividend — HCSG or WELL or SBRA or NHI?
In this comparison, SBRA (5.
8% yield), NHI (4. 8% yield), WELL (1. 3% yield) pay a dividend. HCSG does not pay a meaningful dividend and should not be held primarily for income.
09Is HCSG or WELL or SBRA or NHI better for a retirement portfolio?
For long-horizon retirement investors, National Health Investors, Inc.
(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 4. 8% yield). Both have compounded well over 10 years (NHI: +58. 9%, HCSG: -26. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HCSG and WELL and SBRA and NHI?
These companies operate in different sectors (HCSG (Healthcare) and WELL (Real Estate) and SBRA (Real Estate) and NHI (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HCSG is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock; SBRA is a small-cap income-oriented stock; NHI is a small-cap income-oriented stock. WELL, SBRA, NHI pay a dividend while HCSG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.